GCC PV Training 2025 - Day 2 | Session 5 - Updates On UAE PV Guidelines

20th-Feb-2025 This session focused on the latest developments in the UAE’s pharmacovigilance guidelines based on Emirates Drug Establishment, offering participants practical insights into regulatory expectations and implementation strategies. Moderator: Dr. Yasmine Fekry Middle East Multi Country Safety Head, Global Pharmacovigilance Sanofi Workshop Presentation: Dr. Katya Nabeel Ailabouni Clinical Pharmacist & Pharmacovigilance Officer Emirates Drug Establishment (EDE), UAE Dr. Ailabouni delivered an in-depth workshop on the UAE’s updated PV guidelines, highlighting key regulatory changes, reporting requirements, and best practices to strengthen compliance and enhance medicine safety. The session equipped participants with an up-to-date understanding of the UAE PV framework, reinforcing the country’s ongoing efforts to align with global standards and safeguard patient health. For more information, please visit: https://pramagcc.com/pv